Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Hitting Coronaviruses Where It Hurts: Antiviral Strategies Targeting Viral Proteins. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41579‐020‐00459‐7
10.1038/s41579‐020‐00459‐7 · External reference
Unresolved reference
External reference
10.1177/135965350701200s01.1
10.1177/135965350701200s01.1 · External reference
10.1007/s12098‐020‐03263‐6
10.1007/s12098‐020‐03263‐6 · External reference
10.1128/mmbr.00015‐08
10.1128/mmbr.00015‐08 · External reference
10.3390/ijerph17093161
10.3390/ijerph17093161 · External reference
10.3892/ijmm
10.3892/ijmm · External reference
Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China
10.1016/s0140-6736(20)30183-5 · 2020 · External reference
Extrapulmonary Manifestations of COVID‐19
10.1038/s41591-020-0968-3 · 2020 · External reference
10.3390/v11020174
10.3390/v11020174 · External reference
10.1038/s41579‐018‐0118‐9
10.1038/s41579‐018‐0118‐9 · External reference
10.1038/s41579‐021‐00652‐2
10.1038/s41579‐021‐00652‐2 · External reference
10.1016/j.virusres.2007.03.012
10.1016/j.virusres.2007.03.012 · External reference
10.1186/s12985‐016‐0544‐0
10.1186/s12985‐016‐0544‐0 · External reference
10.1016/j.cub.2020.03.022
10.1016/j.cub.2020.03.022 · External reference
Airborne Transmission of Respiratory Viruses
10.1126/science.abd9149 · 2021 · External reference
10.1038/s41579‐021‐00535‐6
10.1038/s41579‐021‐00535‐6 · External reference
10.1111/tbed.v68.2
10.1111/tbed.v68.2 · External reference
10.1007/s10389‐021‐01478‐1
10.1007/s10389‐021‐01478‐1 · External reference
10.1038/s41598‐021‐83229‐6
10.1038/s41598‐021‐83229‐6 · External reference
10.1038/s41467‐021‐25166‐6
10.1038/s41467‐021‐25166‐6 · External reference
10.1128/jvi.01253‐21
10.1128/jvi.01253‐21 · External reference
10.2478/acph‐2020‐0024
10.2478/acph‐2020‐0024 · External reference
Coronaviruses: An Overview of Their Replica7on and Pathogenesis
10.1007/978-1-4939-2438-7_1 · 2015 · External reference
10.1016/0042‐6822(92)90521‐p
10.1016/0042‐6822(92)90521‐p · External reference
10.1146/virology.2016.3.issue‐1
10.1146/virology.2016.3.issue‐1 · External reference
10.1016/j.cell.2020.02.058
10.1016/j.cell.2020.02.058 · External reference
10.1016/j.celrep.2020.108234
10.1016/j.celrep.2020.108234 · External reference
10.1128/jvi.72.8.6511‐6519.1998
10.1128/jvi.72.8.6511‐6519.1998 · External reference
10.3390/v4061011
10.3390/v4061011 · External reference
10.1016/j.ymthe.2022.02.014
10.1016/j.ymthe.2022.02.014 · External reference
What Do We Know About the Function of SARS‐CoV‐2 Proteins?
2023 · External reference
A Unifying Structural and Functional Model of the Coronavirus Replication Organelle: Tracking Down RNA Synthesis
10.1371/journal.pbio.3000715 · 2020 · External reference
10.3390/cells9051267
10.3390/cells9051267 · External reference
10.1146/virology.2015.2.issue‐1
10.1146/virology.2015.2.issue‐1 · External reference
10.1016/s0065‐3527(06)66005‐3
10.1016/s0065‐3527(06)66005‐3 · External reference
10.1016/j.virol.2006.11.027
10.1016/j.virol.2006.11.027 · External reference
10.1038/s41580‐021‐00418‐x
10.1038/s41580‐021‐00418‐x · External reference
10.1016/j.chembiol.2014.09.001
10.1016/j.chembiol.2014.09.001 · External reference
10.1128/cmr.00168‐19
10.1128/cmr.00168‐19 · External reference
10.1128/jvi.00912‐14
10.1128/jvi.00912‐14 · External reference
Therapy With a Severe Acute Respiratory Syndrome‐Associated Coronavirus‐Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters
2006 · External reference
10.1128/jvi.02322‐09
10.1128/jvi.02322‐09 · External reference
Unresolved reference
2022 · External reference
10.3390/v16020217
10.3390/v16020217 · External reference
10.1007/s15010‐024‐02245‐6
10.1007/s15010‐024‐02245‐6 · External reference
Resistance Mutations in SARS CoV 2 Delta and Omicron Following Sotrovimab Use
2022 · External reference
10.3390/ph15091084
10.3390/ph15091084 · External reference
10.1021/acsomega.5c10442
10.1021/acsomega.5c10442 · External reference
10.1038/s41392‐023‐01472‐x
10.1038/s41392‐023‐01472‐x · External reference
10.1128/aac.03011‐14
10.1128/aac.03011‐14 · External reference
10.1038/s41421‐020‐0169‐8
10.1038/s41421‐020‐0169‐8 · External reference
10.3390/v14010119
10.3390/v14010119 · External reference
Literature Analysis of the Efficacy of Arbidol in Virus Infectious Diseases
2021 · External reference
10.3390/ijms19020487
10.3390/ijms19020487 · External reference
10.1038/s41422‐020‐0305‐x
10.1038/s41422‐020‐0305‐x · External reference
10.1080/22221751.2023.2178241
10.1080/22221751.2023.2178241 · External reference
10.1016/j.cell.2020.02.052
10.1016/j.cell.2020.02.052 · External reference
10.1186/s12879‐024‐09468‐w
10.1186/s12879‐024‐09468‐w · External reference
ARandomized Trial of Nafamostat for COVID‐19
2023 · External reference
10.1021/acs.jmedchem.8b00890
10.1021/acs.jmedchem.8b00890 · External reference
10.1016/b978-0-12-821618-7.00111-5
10.1016/b978-0-12-821618-7.00111-5 · 2023 · External reference
10.1038/s41579‐021‐00630‐8
10.1038/s41579‐021‐00630‐8 · External reference
10.1016/j.antiviral.2014.12.015
10.1016/j.antiviral.2014.12.015 · External reference
10.1038/s41467‐020‐20718‐8
10.1038/s41467‐020‐20718‐8 · External reference
10.1016/j.antiviral.2014.12.011
10.1016/j.antiviral.2014.12.011 · External reference
10.1016/j.antiviral.2017.12.015
10.1016/j.antiviral.2017.12.015 · External reference
10.3389/fchem.2022.876212
10.3389/fchem.2022.876212 · External reference
10.1126/sciadv.abd4596
10.1126/sciadv.abd4596 · External reference
10.1126/sciadv.ado4288
10.1126/sciadv.ado4288 · External reference
10.1038/s41467‐023‐37254‐w
10.1038/s41467‐023‐37254‐w · External reference
10.1126/science.abb7498
10.1126/science.abb7498 · External reference
10.1093/nar/gkae153
10.1093/nar/gkae153 · External reference
10.3390/v10020076
10.3390/v10020076 · External reference
10.1038/s41467‐020‐19770‐1
10.1038/s41467‐020‐19770‐1 · External reference
10.1074/jbc.ra120.013679
10.1074/jbc.ra120.013679 · External reference
10.1016/j.antiviral.2020.104793
10.1016/j.antiviral.2020.104793 · External reference
10.1021/acscentsci.0c00489
10.1021/acscentsci.0c00489 · External reference
10.1002/ardp.v357.1
10.1002/ardp.v357.1 · External reference
10.1016/j.jiph.2023.05.010
10.1016/j.jiph.2023.05.010 · External reference
Mechanism of Molnupiravir Induced SARS CoV 2 Mutagenesis
2020 · External reference
10.1007/s00044‐021‐02841‐3
10.1007/s00044‐021‐02841‐3 · External reference
10.1038/s41594‐021‐00651‐0
10.1038/s41594‐021‐00651‐0 · External reference
Molnupiravir: First Approval
10.1007/s40265-022-01684-5 · 2022 · External reference
10.1186/s40249‐021‐00812‐9
10.1186/s40249‐021‐00812‐9 · External reference
10.1093/nar/gkad660
10.1093/nar/gkad660 · External reference
10.1021/acschembio.4c00244
10.1021/acschembio.4c00244 · External reference
10.1016/j.antiviral.2023.105697
10.1016/j.antiviral.2023.105697 · External reference
10.1128/aac.02994‐14
10.1128/aac.02994‐14 · External reference
10.1021/acs.jpclett.0c02421
10.1021/acs.jpclett.0c02421 · External reference
10.1038/srep40292
10.1038/srep40292 · External reference
Genetic Surveillance of SARS‐CoV‐2 MPro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid
2022 · External reference
10.1126/science.abb4489
10.1126/science.abb4489 · External reference
10.1371/journal.pbio.0030324
10.1371/journal.pbio.0030324 · External reference
10.1371/journal.ppat.1005531
10.1371/journal.ppat.1005531 · External reference
10.1128/aac.47.12.3907‐3916.2003
10.1128/aac.47.12.3907‐3916.2003 · External reference
10.1021/acs.jmedchem.5b01013
10.1021/acs.jmedchem.5b01013 · External reference
10.1126/science.1085658
10.1126/science.1085658 · External reference
10.1073/pnas.1835675100
10.1073/pnas.1835675100 · External reference
10.1126/science.abb3405
10.1126/science.abb3405 · External reference
10.1093/emboj/cdf327
10.1093/emboj/cdf327 · External reference
10.1038/s41586‐020‐2223‐y
10.1038/s41586‐020‐2223‐y · External reference
10.1021/acs.jmedchem.0c01063
10.1021/acs.jmedchem.0c01063 · External reference
10.3390/molecules27082523
10.3390/molecules27082523 · External reference
10.3389/fchem.2022.852210
10.3389/fchem.2022.852210 · External reference
10.1016/j.ejmech.2013.07.037
10.1016/j.ejmech.2013.07.037 · External reference
10.1038/s42003‐020‐0826‐3
10.1038/s42003‐020‐0826‐3 · External reference
10.1093/nar/17.20.8207
10.1093/nar/17.20.8207 · External reference
10.1021/cb500512z
10.1021/cb500512z · External reference
10.3390/molecules13112740
10.3390/molecules13112740 · External reference
10.3390/md20030163
10.3390/md20030163 · External reference
10.1016/j.ejmech.2021.114030
10.1016/j.ejmech.2021.114030 · External reference
10.3390/ph15081021
10.3390/ph15081021 · External reference
10.1016/j.str.2023.06.010
10.1016/j.str.2023.06.010 · External reference
10.3390/biom14070797
10.3390/biom14070797 · External reference
Unresolved reference
2022 · External reference
Ensitrelvir Fumaric Acid: First Approval
10.1007/s40265-024-02039-y · 2024 · External reference
Unresolved reference
2026 · External reference
10.1371/journal.pbio.3000715
10.1371/journal.pbio.3000715 · External reference
10.1186/s12985‐019‐1182‐0
10.1186/s12985‐019‐1182‐0 · External reference
10.1073/pnas.0508200103
10.1073/pnas.0508200103 · External reference
The Coronavirus nsp14 Exoribonuclease Interface With the Cofactor nsp10 Is Essential for Efficient Virus Replication and Enzymatic Activity
2025 · External reference
10.1093/nar/gkab1279
10.1093/nar/gkab1279 · External reference
10.1038/s41467‐025‐64674‐7
10.1038/s41467‐025‐64674‐7 · External reference
10.1039/d4md00422a
10.1039/d4md00422a · External reference
10.1039/d5md00896d
10.1039/d5md00896d · External reference
10.1021/acs.jmedchem.2c00120
10.1021/acs.jmedchem.2c00120 · External reference
10.1016/j.antiviral.2024.105921
10.1016/j.antiviral.2024.105921 · External reference
10.1038/s42003‐021‐01735‐9
10.1038/s42003‐021‐01735‐9 · External reference
10.1371/journal.ppat.1012571
10.1371/journal.ppat.1012571 · External reference
10.1016/j.jbc.2023.105341
10.1016/j.jbc.2023.105341 · External reference
10.1002/cmdc.v19.24
10.1002/cmdc.v19.24 · External reference
10.1371/journal.ppat.1002059
10.1371/journal.ppat.1002059 · External reference
SARS‐CoV‐2 Methyltransferase nsp10‐16 in Complex With Natural and Drug‐Like Purine Analogs for Guiding Structure‐Based Drug Discovery
2024 · External reference
10.3390/molecules28030988
10.3390/molecules28030988 · External reference
10.1002/pro.v31.9
10.1002/pro.v31.9 · External reference
10.1128/jvi.00948‐15
10.1128/jvi.00948‐15 · External reference
10.3390/molecules29102312
10.3390/molecules29102312 · External reference
10.3390/v13061115
10.3390/v13061115 · External reference
10.1021/jm500089r
10.1021/jm500089r · External reference
Effective Inhibition of MERS‐CoV Infection by Resveratrol
10.1186/s12879-017-2253-8 · 2017 · External reference
10.3389/fmicb.2026.1762041
10.3389/fmicb.2026.1762041 · External reference
10.1038/s41586‐025‐08773‐x
10.1038/s41586‐025‐08773‐x · External reference
10.1038/s41586‐025‐08651‐6
10.1038/s41586‐025‐08651‐6 · External reference
10.1016/j.biopha.2023.114242
10.1016/j.biopha.2023.114242 · External reference
10.29245/2578‐3009
10.29245/2578‐3009 · External reference
10.1016/j.virol.2006.05.028
10.1016/j.virol.2006.05.028 · External reference
10.1002/pro.v32.10
10.1002/pro.v32.10 · External reference
10.1038/s41401‐021‐00732‐2
10.1038/s41401‐021‐00732‐2 · External reference
10.1093/infdis/jiw080
10.1093/infdis/jiw080 · External reference
10.3390/v11010060
10.3390/v11010060 · External reference
Unresolved reference
2022 · External reference
10.1136/bmj.m1849
10.1136/bmj.m1849 · External reference
Unresolved reference
2024 · External reference
Double‐Blind, Placebo‐Controlled Trial of Efficacy, Safety and Tolerability of Antiviral Drug Umifenovir Vs Standard Care of Therapy in Non‐Severe COVID‐19 Patients
2021 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2020 · External reference
Unresolved reference
2023 · External reference
10.1016/s2213‐2600(22)00412‐x
10.1016/s2213‐2600(22)00412‐x · External reference
Molnupiravir: First Approval
10.1007/s40265-022-01684-5 · 2022 · External reference
Unresolved reference
2023 · External reference
10.1126/scitranslmed.abc5332
10.1126/scitranslmed.abc5332 · External reference
Unresolved reference
2023 · External reference
Unresolved reference
2023 · External reference
